NASDAQ · Specialty Chemicals · USD
Bon Natural Life Limited (BON) Stock Analysis
Bon Natural Life Limited (BON) is a Specialty Chemicals stock listed on NASDAQ and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
BON Key Statistics
As of Sep 4, 2026Trading
- Open
- $1.12
- Previous Close
- $1.13
- Day's Range
- 1.12–1.16
- 52-Week Range
- 1.05–3.40
- Volume
- 1.50K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- −0.24
Valuation
- Market Cap
- $11.80M
- P/E Ratio
- unprofitable
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 2.00
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 0.63
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −0.74
Financials (FY)
- Revenue (FY)
- $18.67M−21.70%
- Net Income (FY)
- −$1.99M−600.98%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- −10.68%
- Shares Outstanding
- 6.09M
- 1-Year Return
- −23.68%
Dividend and dates
- Avg Volume
- 12.11K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
BON Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −27.04% |
| 2025 | −96.41% |
| 2024 | −67.22% |
| 2023 | −48.91% |
| 2022 | −76.25% |
| 2021 (partial year) | −38.19% |
As of September 4, 2026.
BON Revenue and Earnings by Fiscal Year
FY ends September| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $18.67M | −$1.99M | −10.7% |
| 2024 | $23.84M | $398.17K | 1.7% |
| 2023 | $29.52M | $4.60M | 15.6% |
| 2022 | $29.91M | $6.24M | 20.9% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $18.67M | $3.88M | −$1.59M | −$1.99M | −10.7% |
| 2024 | $23.84M | $7.11M | $1.94M | $398.17K | 1.7% |
| 2023 | $29.52M | $8.84M | $5.96M | $4.60M | 15.6% |
| 2022 | $29.91M | $9.42M | $7.91M | $6.24M | 20.9% |
Annual figures as reported, in the company's reporting currency. As of September 30, 2025.
BON Valuation vs Specialty Chemicals Median
Median of 71 stocks| Metric | BON | Specialty Chemicals median | vs median |
|---|---|---|---|
| P/S ratio | 0.63 | 1.68 | 62% below |
| Profit margin | −10.68% | 0.08% | 10.8 pts below |
Medians across 71 Specialty Chemicals stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Specialty Chemicals Stocks
Linde plc
$220.15B
SHWThe Sherwin-Williams Company
$81.01B
ECLEcolab Inc.
$78.29B
APDAir Products and Chemicals, Inc.
$67.09B
PPGPPG Industries, Inc.
$25.02B
IFFInternational Flavors & Fragrances Inc.
$22.03B
Popular Basic Materials Stocks
BHP Group Limited
$229.80B
RIORio Tinto Group
$167.95B
SCCOSouthern Copper Corporation
$167.82B
NEMNewmont Corporation
$134.97B
FCXFreeport-McMoRan Inc.
$104.44B